2026-09-21T06:32:11Z https://www.ideals.illinois.edu/oai-pmh

oai:www.ideals.illinois.edu:2142/19008 2023-07-10 col_2142_14789 col_2142_5131 com_2142_14788 com_2142_8903 com_2142_5130

Pomper, Martin Gilbert 2011-05-07T11:54:10Z 2011-05-07T11:54:10Z 10000-01-01 1989 Estrogens can be labeled with the positron-emitting radionuclide fluorine-18 (t$\sb{1/2}$ = 110 min) by fluoride ion (n-Bu$\sb4$N$\sp{18}$F) displacement of a 16$\beta$-trifluoromethanesulfonate (triflate) derivative of the corresponding estrone 3-triflate, and purification by HPLC. That sequence has been used to synthesize the 11$\beta$-methoxy 1 and 11$\beta$-ethyl 2 analogues of the breast tumor imaging agent, 16$\alpha$-($\sp{18}$F) fluoro-17$\beta$-estradiol (FES). Tissue distribution studies of 1 and 2 in immature female rats show high selectivity for target tissue (T, uterus) vs non-target (NT, muscle and lung), with T/NT ratios being 43 and 17 at one hour after injection for 1 and 2, respectively. The parent estrogen FES has previously been shown to display an intermediate value for tissue selectivity. The progestin 21-($\sp{18}$F) fluoro-16$\alpha$-ethyl-19-norprogesterone (FENP), synthesized from the 21-triflate precursor, is a high affinity ligand for the progestin receptor, and in vivo, exhibits highly selective uptake by the uterus of estrogen-primed rats. Respective T/NT ratios of 16 and 41 at one and 3 hours after injection have been demonstrated. Two epimeric (at C-21) analogues of the high affinity progestin promegestone (R 5020) were prepared in fluorine-18 labeled form from the corresponding triflate precursors; while 21S-($\sp{18}$F) R 5020 3 showed a T/NT ratio of 4 at 3 hours after injection, 21R-($\sp{18}$F) R 5020 4 showed no selective uptake. Compounds 3 and 4 each suffered extensive in vivo defluorination. Derivatives of the high affinity Type I and Type II corticosteroid receptor ligands RU 26752 and RU 28362, respectively, were prepared in fluorine-18 labeled form from the corresponding 3$\sp\prime$-methanesulfonates. Neither labeled compound showed selective target tissue (brain) uptake and each underwent substantial in vivo defluorination. 1,2-($\sp3$H$\sb2$) RU 26752 was also synthesized (52 Ci/mmol) as a potential Type I receptor probe. These fluorine-18 labeled steroids can be prepared within 2 hours of the end of bombardment, and their specific activities range from 500-4000 Ci/mmol. The high target tissue selectivities and uterine uptake values for 1, 2 and FENP suggest that these compounds may be useful for in vivo imaging of estrogen and progestin target tissues and tumors (such as human breast tumors) by positron emission tomography. Made available in DSpace on 2011-05-07T11:54:10Z (GMT). No. of bitstreams: 2 license.txt: 4922 bytes, checksum: 910b249b4beec47e7ab768910c8f966f (MD5) 9010990.pdf: 6947901 bytes, checksum: f4d3c08a86c27acb5edea04e9240a00c (MD5) Previous issue date: 1989 Item marked as restricted to the 'UIUC Users [automated]' Group (id=2) by Howard Ding (hding2@illinois.edu) on 2011-05-07T14:34:02Z Item is restricted indefinitely. Restriction data tranferred 2014-07-01T11:12:49-05:00 Original Data Group with Access UIUC Users [automated] Release Date: none Reason: ETDs are only available to UIUC Users without author permission ETDs are only available to UIUC Users without author permission U of I Only AAI9010990 (UMI)AAI9010990 http://hdl.handle.net/2142/19008 eng Copyright 1989 Pomper, Martin Gilbert Organic Chemistry Pharmaceutical Chemistry Health Sciences Radiology Fluorine-18-labeled estrogens, progestins and corticosteroids for receptor-based imaging of breast tumors and target areas of the brain text Chemistry Chemistry University of Illinois at Urbana-Champaign Dissertation Ph.D.